Position
Principal
Company
Gain Therapeutics
Description
On October 22, 2026, Gain Therapeutics, Inc. appointed Jeanette Weidner as Vice President of Finance, effective October 28, 2026. Ms
Other recent leadership changes in Therapeutics and Biotechnology
Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.
- NovaBridge Appoints Chuck as Chief Executive Officer (October 28, 2026)
- Celea Therapeutics Appoints Paul Audhya as Chief Medical Officer (October 29, 2026)
- Spica Therapeutics Appoints Jeff Abbey as Chief Executive Officer (October 28, 2026)
- United Theranostics Appoints Amber Woodward-Smith as Chief Financial Officer (October 29, 2026)
- IRulya Therapeutics Appoints Brigette Roberts as Chief Executive Officer (October 30, 2026)
- Faeth Therapeutics Appoints Adam Schayowitz as Class III Director (October 27, 2026)
Who to call at Gain Therapeutics, and when
A new leader at Gain Therapeutics brings new priorities and often new vendors. The first weeks are when they listen.
- An alert the day Gain Therapeutics raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Gain Therapeutics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Gain Therapeutics. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Gain Therapeutics changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Gain Therapeutics changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.